Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Rosati

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Elife|February 22, 2020
Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clonesAnastasia A Minervina, Mikhail V Pogorelyy, Ekaterina A Komech, et al.
Elife|January 5, 2021
Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infectionAnastasia A Minervina, Ekaterina A Komech, Aleksei Titov, et al.
Frontiers in Immunology|August 9, 2018
The Changing Landscape of Naive T Cell Receptor Repertoire With Human AgingEvgeny S Egorov, Sofya A Kasatskaya, Vasiliy N Zubov, et al.
Radiology|November 21, 2023
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical ProstatectomyStefano Luzzago, Alberto Colombo, Francesco A Mistretta, et al.
Cell Host & Microbe|March 9, 2023
Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver diseaseSuling Zeng, Elisa Rosati, Carina Saggau, et al.
Gut|May 7, 2018
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel diseaseSebastian Zeissig, Elisa Rosati, C Marie Dowds, et al.
Oncotarget|September 8, 2018
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissueMichael Forster, Adam Mark, Friederike Egberts, et al.
The Journal of Clinical Investigation|January 26, 2023
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosisCarsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, et al.
Journal of Crohn'S & Colitis|March 22, 2025
Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseasesMitchell Pesesky, Ramit Bharanikumar, Lionel Le Bourhis, et al.
Immunity|December 9, 2020
Low-Avidity CD4<sup>+</sup> T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19Petra Bacher, Elisa Rosati, Daniela Esser, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Elife|February 22, 2020
Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clonesAnastasia A Minervina, Mikhail V Pogorelyy, Ekaterina A Komech, et al.
Elife|January 5, 2021
Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infectionAnastasia A Minervina, Ekaterina A Komech, Aleksei Titov, et al.
Frontiers in Immunology|August 9, 2018
The Changing Landscape of Naive T Cell Receptor Repertoire With Human AgingEvgeny S Egorov, Sofya A Kasatskaya, Vasiliy N Zubov, et al.
Radiology|November 21, 2023
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical ProstatectomyStefano Luzzago, Alberto Colombo, Francesco A Mistretta, et al.
Cell Host & Microbe|March 9, 2023
Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver diseaseSuling Zeng, Elisa Rosati, Carina Saggau, et al.
Gut|May 7, 2018
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel diseaseSebastian Zeissig, Elisa Rosati, C Marie Dowds, et al.
Oncotarget|September 8, 2018
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissueMichael Forster, Adam Mark, Friederike Egberts, et al.
The Journal of Clinical Investigation|January 26, 2023
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosisCarsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, et al.
Journal of Crohn'S & Colitis|March 22, 2025
Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseasesMitchell Pesesky, Ramit Bharanikumar, Lionel Le Bourhis, et al.
Immunity|December 9, 2020
Low-Avidity CD4<sup>+</sup> T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19Petra Bacher, Elisa Rosati, Daniela Esser, et al.
Pageof 4